Dr. William Galanter, assistant professor of pharmacy at University of Illinois College of Medicine, discusses the ongoing relationship between physicians and drug representatives and how the 19 billion dollars that pharmaceutical companies spend on this "educational/marketing tool" can be used to provide the best and most cost effective care for our patients. Education institutions must teach young learners how to evaluate the literature that is not biased so that they are not overwhelmed by industrial pressures their first day in practice.
Pharmaceutical Representatives are Not Going Away. How Can They Help Us Most?

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. William Galanter, assistant professor of pharmacy at University of Illinois College of Medicine, discusses the ongoing relationship between physicians and drug representatives and how the 19 billion dollars that pharmaceutical companies spend on this "educational/marketing tool" can be used to provide the best and most cost effective care for our patients. Education institutions must teach young learners how to evaluate the literature that is not biased so that they are not overwhelmed by industrial pressures their first day in practice.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Diagnosis and Management of Metastatic PDAC
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?